This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BOOK BY MIDNIGHT OCTOBER 29 TO SAVE $400!

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Sophie Steeland, Ph.D.
Senior Clinical Scientist at argenx

Profile

I have a master in Pharmaceutical Drug Development, and hold a PhD in Biotechnology obtained at the VIB-Inflammation Research Center (IRC) in Ghent. My PhD focused on the development of Nanobody-based therapeutics against inflammatory targets such as TNF receptor-1 in neurological disorders. Since January 2019, I am working at argenx and I am now the scientific lead on the efgartigimod myasthenia gravis programs.

Agenda Sessions

  • Clinical Development of FcRn Inhibitor Efgartigimod in IgG-driven Autoimmune Disorders

    9:15am